Login

Akoya Biosciences, Inc. SEC Filings

Filed On Filing
18 Jul 2025 15-12G
11 Jul 2025 EFFECT
10 Jul 2025 Form 4: Mendel Scott, Director

Disposed of 28,500 shares (Other Transaction) · Disposed of 217,392 Stock Option (right to buy) (Other Transaction)

10 Jul 2025 Form 4: Ramachandran Niro Ph.D, Chief Business Officer

Acquired 62,566 shares (Other Transaction) · Gave up 42,148 shares to cover exercise price or tax · Disposed of 282,555 shares (Other Transaction) · 2 more

10 Jul 2025 Form 4: McKelligon Brian, Director

Acquired 724,428 shares (Other Transaction) · Gave up 196,866 shares to cover exercise price or tax · Disposed of 947,688 shares (Other Transaction) · 1 more

10 Jul 2025 Form 4: Kamocsay Jennifer, Chief Legal Officer

Disposed of 179,272 shares (Other Transaction) · Disposed of 145,000 Employee Stock Option (Right to Buy) (Other Transaction)

10 Jul 2025 Form 4: Ek John Frederick, CFO

Disposed of 268,202 shares (Other Transaction) · Disposed of 230,000 Employee Stock Option (Right to Buy) (Other Transaction)

10 Jul 2025 Form 4: Bamford Pascal, Chief Clinical Officer

Disposed of 205,738 shares (Other Transaction) · Disposed of 240,000 Employee Stock Option (Right to Buy) (Other Transaction)

10 Jul 2025 Form 4: Winkler Matthew, Director

Disposed of 984,513 shares (Other Transaction) · Disposed of 16,860 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)

10 Jul 2025 Form 4: Shepler Robert G, Director

Disposed of 16,860 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)

10 Jul 2025 Form 4: Schnettler Thomas P, Director

Disposed of 16,860 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)

10 Jul 2025 Form 4: Raffin Thomas A., Director

Disposed of 17,909,839 shares (Other Transaction) · Disposed of 16,860 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)

10 Jul 2025 Form 4: Lai Goldman Myla, Director

Disposed of 20,000 shares (Other Transaction) · Disposed of 38,993 Stock Option (Right to Buy) (Other Transaction) · Disposed of 136,871 Stock Option (right to buy) (Other Transaction)

08 Jul 2025 S-8 POS
08 Jul 2025 S-8 POS
08 Jul 2025 S-8 POS
08 Jul 2025 S-8 POS
08 Jul 2025 S-8 POS
08 Jul 2025 POS AM
08 Jul 2025 25-NSE

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support